HCW BIOLOGICS INC
HCWB · NASDAQ
更新于 2026-10-14 09:34:49
- 今日最高
- $1.45
- 今日最低
- $1.25
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $1.56
- 昨日收盘价
- $1.48
- 成交量
- 4.29万
- 市值
- $330.97万
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-10.91
昨日价格区间
52周价格区间
公司概况
- 板块
- HEALTHCARE
- 行业
- Biotechnology
- 子行业
- BIOTECHNOLOGY
- 总部
- 2929 NORTH COMMERCE PARKWAY, MIRAMAR, FL, UNITED STATES, 33025
- 国家
- US
- 上市日期
- 2021-07-20
- 财年截止
- December
- 流通股数
- 160万
- CIK
- 0001828673
- 官方网址
- hcwbiologics.com
HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues such as cancer and infectious diseases. Utilizing its proprietary platforms to amplify immune responses, HCW Biologics is actively expanding a promising pipeline of clinical candidates poised to make significant impacts in patient care. With a keen commitment to strategic partnerships and addressing urgent medical needs, the company aims to establish itself as a competitive force in the biotechnology landscape, presenting compelling investment opportunities that align with the evolving dynamics of the healthcare sector.
财务指标
营业收入
2026-06-30
$13.55万
2026-03-31
$654.3万
2025-12-31
$2.7万
2025-09-30
$1.56万
营业支出
2026-06-30
$307.24万
2026-03-31
$328.51万
2025-12-31
$295.28万
2025-09-30
$327.97万
净利润
2026-06-30
-$521.92万
2026-03-31
$413.28万
2025-12-31
$71.92万
2025-09-30
-$455.43万
净利润率
2026-06-30
-3.84K%
2026-03-31
63.16%
2025-12-31
2.66K%
2025-09-30
-29.18K%
每股收益
2026-06-30
$-10.10
2026-03-31
$2.22
2025-12-31
$-6.12
2025-09-30
$-12.12
息税折旧摊销前利润
2026-06-30
-$497.23万
2026-03-31
$383.54万
2025-12-31
$110.27万
2025-09-30
-$423.78万
有效税率
2026-06-30
-195.28%
2026-03-31
-8.68%
2025-12-31
--
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $13.55万 | $654.3万 | $2.7万 | $1.56万 |
| 营业支出 | $307.24万 | $328.51万 | $295.28万 | $327.97万 |
| 净利润 | -$521.92万 | $413.28万 | $71.92万 | -$455.43万 |
| 净利润率 | -3.84K% | 63.16% | 2.66K% | -29.18K% |
| 每股收益 | $-10.10 | $2.22 | $-6.12 | $-12.12 |
| 息税折旧摊销前利润 | -$497.23万 | $383.54万 | $110.27万 | -$423.78万 |
| 有效税率 | -195.28% | -8.68% | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。